scholarly journals Inequalities in the distribution of National Institutes of Health research project grant funding

eLife ◽  
2021 ◽  
Vol 10 ◽  
Author(s):  
Michael S Lauer ◽  
Deepshikha Roychowdhury

Previous reports have described worsening inequalities of National Institutes of Health (NIH) funding. We analyzed Research Project Grant data through the end of Fiscal Year 2020, confirming worsening inequalities beginning at the time of the NIH budget doubling (1998-2003), while finding that trends in recent years have reversed for both investigators and institutions, but only to a modest degree. We also find that career-stage trends have stabilized, with equivalent proportions of early-, mid-, and late-career investigators funded from 2017 to 2020. The fraction of women among funded PIs continues to increase, but they are still not at parity. Analyses of funding inequalities show that inequalities for investigators, and to a lesser degree for institutions, have consistently been greater within groups (i.e., within groups by career stage, gender, race, and degree) than between groups.

2021 ◽  
Author(s):  
Michael S Lauer ◽  
Deepshikha Roychowdhury

Previous reports have described worsening inequalities of National Institutes of Health (NIH) funding of principal investigators. We analyzed data through the end of Fiscal Year 2020, confirming worsening inequalities beginning at the time of the NIH budget doubling (1998-2003), but finding that trends have reversed over the past 3 years. We also find that career-stage trends have stabilized, with equivalent proportions of early-, mid-, and late-career investigators funded from 2017 to 2020. Women continue to constitute a greater proportion of funded principal investigators, though not at parity. Analyses of funding inequalities over time show that inequalities have consistently been greater within groups (i.e., within groups by career stage, gender, race, and degree) than between groups.


JAMA ◽  
2007 ◽  
Vol 297 (22) ◽  
pp. 2496 ◽  
Author(s):  
Howard B. Dickler ◽  
Di Fang ◽  
Stephen J. Heinig ◽  
Elizabeth Johnson ◽  
David Korn

2018 ◽  
Vol 33 (2) ◽  
pp. 279-284
Author(s):  
Ashley L. Merianos ◽  
Judith S. Gordon ◽  
Kelsi J. Wood ◽  
E. Melinda Mahabee-Gittens

Purpose: The study objective was to describe and compare changes in newly funded National Institutes of Health (NIH) tobacco-related awards between fiscal year (FY) 2006 and FY2016. Design: Secondary analysis of NIH data. Setting: National Institutes of Health Research Portfolio Online Reporting Tool database was used. Subjects: National Institutes of Health tobacco-related awards newly funded during FY2006 and FY2016. Measures: Search terms included tobacco, smoking, nicotine, secondhand smoke, and e-cigarettes. Grants and funding amounts were retrieved. Analysis: We calculated frequency distributions to determine the number and percentage of total NIH grants funded overall and by specific institute, and inflation-adjusted total and median funding amounts. We computed percentage differences in number of new grants, funding amounts, and percentage of funding allocated overall, and by institute. Results: There was a 187% increase in the percentage of total NIH funding allocated to new tobacco-related awards from 0.09% in FY2006 to 0.25% in FY2016. Total number of awards increased by 67% in FY2016 (n = 144; $56 015 931) compared to FY2006 (n = 86; $22 076 987), and there was a 154% increase in inflation-adjusted total funding for tobacco control. The top funding institutes were National Institute on Drug Abuse and National Cancer Institute; National Institute on Alcohol Abuse and Alcoholism was third in FY2006; and National, Heart, Lung and Blood Institute in FY2016. Research grants were the most frequently funded. Smoking cessation was a common topic area and increased by 64%. Conclusion: NIH funding is critical for advancing the science of nicotine and tobacco research.


2020 ◽  
Author(s):  
Pragati Katiyar ◽  
Catherine Nagy ◽  
Samir Sauma ◽  
Marie A Bernard

Abstract Since 2015, the National Institute on Aging (NIA), National Institutes of Health (NIH), has experienced significant increases in funding for Alzheimer’s disease and Alzheimer’s disease-related dementias (AD/ADRD). This analysis assesses the impact of these funds on expanding the AD/ADRD workforce. NIA administered 860 awards to 695 AD/ADRD R01 awardees during fiscal year 2015–2018. Twenty-nine percent of awardees were new or early-stage investigators, while 38% were new to the AD/ADRD research field (NTF). Among these NTFs, 59% were established investigators, that is, experts with NIH funding in another discipline but new to AD/ADRD research. Awards were further analyzed to determine the focus of their research based on International Alzheimer’s Disease Research Portfolio (IADRP) categories. Forty-six percent were focused on Molecular Pathogenesis and Physiology. Other IADRP categories, including Diagnosis, Assessment, and Disease Monitoring and Translational Research and Clinical Interventions, represented 5%–15% of awards. Significantly, NTF investigators received 50%, 42%, and 70% of the total grants awarded in Population Studies, Dementia Care, and Brain Aging, respectively, suggesting that NTF investigators are filling research gaps. While these results suggest that enhanced funding is associated with recruitment of new talent, opportunities for further growth remain, particularly related to care, caregiving, and health disparities.


Sign in / Sign up

Export Citation Format

Share Document